Healthia Management
Management criteria checks 3/4
Healthia's CEO is Wes Coote, appointed in Apr 2019, has a tenure of 4.67 years. total yearly compensation is A$660.60K, comprised of 60.2% salary and 39.8% bonuses, including company stock and options. directly owns 1.42% of the company’s shares, worth A$3.58M. The average tenure of the management team and the board of directors is 1.4 years and 5.6 years respectively.
Key information
Wes Coote
Chief executive officer
AU$660.6k
Total compensation
| CEO salary percentage | 60.2% |
| CEO tenure | 4.7yrs |
| CEO ownership | 1.4% |
| Management average tenure | 1.4yrs |
| Board average tenure | 5.6yrs |
Recent management updates
Recent updates
Calculating The Fair Value Of Healthia Limited (ASX:HLA)
Jan 30
Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02
Mar 02Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise
Nov 09Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%
Sep 17Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable
Sep 17Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025
Sep 01I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease
Aug 17Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?
May 19Is Healthia (ASX:HLA) A Risky Investment?
Apr 19With EPS Growth And More, Healthia (ASX:HLA) Is Interesting
Apr 03Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year
Mar 19Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares
Mar 06What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?
Feb 26Is There Now An Opportunity In Healthia Limited (ASX:HLA)?
Feb 09Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 19Why Dividend Hunters Love Healthia Limited (ASX:HLA)
Dec 29Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?
Dec 10We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings
Nov 20
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | AU$661k | AU$398k | AU$5m |
| Mar 31 2023 | n/a | n/a | AU$3m |
| Dec 31 2022 | n/a | n/a | AU$781k |
| Sep 30 2022 | n/a | n/a | -AU$1m |
| Jun 30 2022 | AU$516k | AU$345k | -AU$3m |
| Mar 31 2022 | n/a | n/a | -AU$2m |
| Dec 31 2021 | n/a | n/a | AU$161k |
| Sep 30 2021 | n/a | n/a | AU$3m |
| Jun 30 2021 | AU$400k | AU$306k | AU$5m |
| Mar 31 2021 | n/a | n/a | AU$6m |
| Dec 31 2020 | n/a | n/a | AU$7m |
| Sep 30 2020 | n/a | n/a | AU$5m |
| Jun 30 2020 | AU$313k | AU$225k | AU$3m |
| Mar 31 2020 | n/a | n/a | AU$1m |
| Dec 31 2019 | n/a | n/a | AU$271k |
| Sep 30 2019 | n/a | n/a | -AU$483k |
| Jun 30 2019 | AU$226k | AU$176k | -AU$1m |
Compensation vs Market: Wes's total compensation ($USD439.78K) is about average for companies of similar size in the Australian market ($USD622.80K).
Compensation vs Earnings: Wes's compensation has been consistent with company performance over the past year.
CEO
Wes Coote
4.7yrs
Tenure
AU$660,599
Compensation
Mr. Wesley James Coote, also known as Wes, B.Com., C.A., ACIS, serves as the Managing Director of Evolve Salons Limited. Mr. Coote has been Group Managing Director, Chief Executive Officer and Director at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group MD | 4.7yrs | AU$660.60k | 1.42% A$ 3.6m | |
| Group Chief Financial Officer | less than a year | AU$319.83k | no data | |
| Director of Podiatry & Executive Director | no data | AU$115.34k | 6.4% A$ 16.1m | |
| Group Chief Partnerships Officer & Executive Director | less than a year | AU$391.84k | 0.75% A$ 1.9m | |
| CEO of Eyes & Ears Division and Director | 2.7yrs | AU$368.92k | 3.66% A$ 9.2m | |
| Chief Executive Officer of Bodies | less than a year | AU$314.24k | no data | |
| Chief Technology Officer | 1.9yrs | AU$261.49k | 2.49% A$ 6.3m | |
| General Counsel & Company Secretary | 1.8yrs | no data | no data | |
| Group Chief Business Development & Strategy Officer | no data | AU$341.32k | 0% A$ 0 | |
| Group Chief Education & Research Officer | no data | no data | no data | |
| Chief Operating Officer of Eyes & Ears Division | less than a year | no data | no data |
1.4yrs
Average Tenure
Experienced Management: HLA's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group MD | 4.7yrs | AU$660.60k | 1.42% A$ 3.6m | |
| Director of Podiatry & Executive Director | 5.6yrs | AU$115.34k | 6.4% A$ 16.1m | |
| Group Chief Partnerships Officer & Executive Director | 1.7yrs | AU$391.84k | 0.75% A$ 1.9m | |
| CEO of Eyes & Ears Division and Director | 2.7yrs | AU$368.92k | 3.66% A$ 9.2m | |
| Non-Executive Chairman | 5.6yrs | AU$130.00k | 5.67% A$ 14.3m | |
| Independent Non-Executive Director | 5.6yrs | AU$80.00k | 2.51% A$ 6.3m | |
| Independent Non-Executive Director | 5.6yrs | AU$80.00k | 0.034% A$ 85.2k |
5.6yrs
Average Tenure
Experienced Board: HLA's board of directors are considered experienced (5.6 years average tenure).